A Study to Evaluate the Safety, Tolerability, PK, PD, and Clinical Activity of EQ001 in Subjects With aGVHD

NCT03763318 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute-graft-versus-host Disease
aGVHD
GVHD
GVHD, Acute

Interventions

BIOLOGICAL: EQ001
BIOLOGICAL: EQ001 Placebo

Sponsor

Equillium

Collaborators

[object Object]